Alexion Pharmaceuticals Reaches Analyst Target Price
April 19, 2021 at 14:25 PM EDT
In recent trading, shares of Alexion Pharmaceuticals Inc. (ALXN) have crossed above the average analyst 12-month target price of $162.25, changing hands for $163.68/share..
